Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal
Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal
复制标题
DOI：
10.1258/004947507781524700
复制
发表时间：
2007-07-01
期刊：
影响因子：
0.6
通讯作者：
Walker, S. L.
中科院分区：
文献类型：
--
作者：
Pandey, B.;Shrestha, K.;Walker, S. L.
氨苯砜是治疗所有类型麻风病的多药疗法的一个组成部分。众所周知，氨苯砜超敏反应综合征（DHS）的治疗复杂化的患者的比例，我们进行了一项回顾性研究的患者开始在1990年和2006年之间的MDT; 2%的开发DHS和0.25%死于DHS。
Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy. It is known that dapsone hypersensitivity syndrome (DHS) complicates the treatment in a proportion of patients.We performed a retrospective study of patients commenced on MDT between 1990 and 2006; 2% developed DHS and 0.25% died due to DHS.